VivoSim Labs Inc. (VIVS)
NASDAQ: VIVS
· Real-Time Price · USD
1.99
0.04 (2.05%)
At close: May 01, 2025, 3:11 PM
2.05% (1D)
| Bid | 1.94 |
| Market Cap | 3.58M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | -10.08 |
| PE Ratio (ttm) | -0.2 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 2.05 |
| Volume | 132,242 |
| Avg. Volume (20D) | 843,776 |
| Open | 1.98 |
| Previous Close | 1.95 |
| Day's Range | 1.93 - 2.06 |
| 52-Week Range | 1.56 - 21.96 |
| Beta | 1.13 |
About VIVS
VivoSim Labs, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised of mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company's lead candidate ...
Industry Healthcare
Sector Healthcare
IPO Date Feb 14, 2012
Employees 14
Stock Exchange NASDAQ
Ticker Symbol VIVS
Website https://www.organovo.com
Next Earnings Release
VivoSim Labs Inc. is scheduled to release its earnings on May 30, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription